Discover the complete record of transactions filed by Peter Ostler, Président du Conseil. Insider active across 6 companies, notably Alligator Bioscience AB. Cumulatively, 7 filings have been published. Activity tracked since 19 May 2025. The latest transaction was filed on 18 December 2025 (Purchase). Regulator: FIN-FSA. All data is openly available.
46,912 shares@ €0.33780.011% mcap70.3% of flowAktieFI:A003O690-1
Ideal exit: 13 Feb 2026 (T+270)
7 of 7 declarations
About Peter Ostler
Peter Ostler is the Chairman of Alligator Bioscience AB. In this role, he oversees the activities of the board of directors and contributes to the strategic direction of the company. Alligator Bioscience AB is a Swedish biopharmaceutical company specializing in the development of cancer treatments. Peter Ostler plays a key role in the governance and development of the company.